About this Journal Submit a Manuscript Table of Contents
Obstetrics and Gynecology International
Volume 2012 (2012), Article ID 147867, 7 pages
http://dx.doi.org/10.1155/2012/147867
Clinical Study

Safety and Efficacy of an Intravaginal Prebiotic Gel in the Prevention of Recurrent Bacterial Vaginosis: A Randomized Double-Blind Study

1Alliospharma, 1 Allée des Ecureuils, 69380 Lissieu, France
2Department of Obstetrics, Gynecology & Reproduction, Maternité Régionale Universitaire, 10 rue du Dr Heydenreich, 54042 Nancy, France
3Novescia, 29 rue de la bienfaisance, 75008 Paris, France

Received 16 October 2012; Accepted 26 November 2012

Academic Editor: Everett Magann

Copyright © 2012 Isabelle Coste et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Donders, “Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review,” Obstetrical and Gynecological Survey, vol. 65, no. 7, pp. 462–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. N. Fredricks, T. L. Fiedler, K. K. Thomas, B. B. Oakley, and J. M. Marrazzo, “Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3270–3276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Olmsted, L. A. Meyn, L. C. Rohan, and S. L. Hillier, “Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis,” Sexually Transmitted Diseases, vol. 30, no. 3, pp. 257–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Hellberg, S. Nilsson, and P. A. Mårdh, “The diagnosis of bacterial vaginosis and vaginal flora changes,” Archives of Gynecology and Obstetrics, vol. 265, no. 1, pp. 11–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. H. Koumans and J. S. Kendrick, “Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda,” Sexually Transmitted Diseases, vol. 28, no. 5, pp. 292–297, 2001. View at Scopus
  6. R. F. O'Brien, “Bacterial vaginosis: many questions—any answers?” Current Opinion in Pediatrics, vol. 17, no. 4, pp. 473–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Nyirjesy, “Vulvovaginal candidiasis and bacterial vaginosis,” Infectious Disease Clinics of North America, vol. 22, no. 4, pp. 637–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Workowski and S. M. Berman, “Sexually transmitted diseases treatment guidelines, 2006,” MMWR—Recommendations and Reports, vol. 55, no. 11, pp. 1–94, 2006. View at Scopus
  9. J. Wilson, “Managing recurrent bacterial vaginosis,” Sexually Transmitted Infections, vol. 80, no. 1, pp. 8–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. Joesoef, G. P. Schmid, and S. L. Hillier, “Bacterial vaginosis: review of treatment options and potential clinical indications for therapy,” Clinical Infectious Diseases, vol. 28, no. 1, pp. S57–S65, 1999. View at Scopus
  11. C. S. Bradshaw, A. N. Morton, J. Hocking et al., “High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence,” Journal of Infectious Diseases, vol. 193, no. 11, pp. 1478–1486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. L. Greaves, J. Chungafung, B. Morris, A. Haile, and J. L. Townsend, “Clandamycin versus metronidazole in the treatment of bacterial vaginosis,” Obstetrics and Gynecology, vol. 72, no. 5, pp. 799–802, 1988. View at Scopus
  13. E. H. Koumans, L. E. Markowitz, and V. Hogan, “Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data,” Clinical Infectious Diseases, vol. 35, no. 2, pp. S152–S172, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. B. Roberfroid, “Prebiotics: preferential substrates for specific germs?” American Journal of Clinical Nutrition, vol. 73, no. 2, pp. 406S–409S, 2001. View at Scopus
  15. D. M. Saulnier, S. Kolida, and G. R. Gibson, “Microbiology of the human intestinal tract and approaches for its dietary modulation,” Current Pharmaceutical Design, vol. 15, no. 13, pp. 1403–1414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. R. Gibson, “Dietary modulation of the human gut microflora using prebiotics,” British Journal of Nutrition, vol. 80, no. 2, pp. S209–S212, 1998. View at Scopus
  17. F. R. J. Bornet, F. Brouns, Y. Tashiro, and V. Duvillier, “Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications,” Digestive and Liver Disease, vol. 34, no. 2, pp. S111–S120, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. B. Roberfroid, J. A. E. Van Loo, and G. R. Gibson, “The bifidogenic nature of chicory inulin and its hydrolysis products,” Journal of Nutrition, vol. 128, no. 1, pp. 11–19, 1998. View at Scopus
  19. J. Grimoud, H. Durand, C. Courtin et al., “In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics,” Anaerobe, vol. 16, no. 5, pp. 493–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Rousseau, J. P. Lepargneur, C. Roques, M. Remaud-Simeon, and F. Paul, “Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms,” Anaerobe, vol. 11, no. 3, pp. 145–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Nugent, M. A. Krohn, and S. L. Hillier, “Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation,” Journal of Clinical Microbiology, vol. 29, no. 2, pp. 297–301, 1991. View at Scopus
  22. K. Van Kessel, N. Assefi, J. Marrazzo, and L. Eckert, “Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review,” Obstetrical and Gynecological Survey, vol. 58, no. 5, pp. 351–358, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. G. Larsson and U. Forsum, “Bacterial vaginosis—a disturbed bacterial flora and treatment enigma,” APMIS, vol. 113, no. 5, pp. 305–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Zhou, M. A. Hansmann, C. C. Davis et al., “The vaginal bacterial communities of Japanese women resemble those of women in other racial groups,” FEMS Immunology and Medical Microbiology, vol. 58, no. 2, pp. 169–181, 2010. View at Publisher · View at Google Scholar · View at Scopus